PHARMA-BIO SERV, INC. Shareholders' Equity
PHARMA-BIO SERV, INC. (PBSV) had Shareholders' Equity of $10.44 million as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-14
- 2026-07-31: Stockholders' Equity Attributable to Parent $10.44M.
- 2026-04-30: Stockholders' Equity Attributable to Parent $10.45M.
- 2026-01-31: Stockholders' Equity Attributable to Parent $10.24M.
- 2025-10-31: Stockholders' Equity Attributable to Parent $11.91M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-07-31 | $10.44M 10-Q · filed 2026-09-14 |
| 2026-04-30 | $10.45M 10-Q · filed 2026-09-14 |
| 2026-01-31 | $10.24M 10-Q · filed 2026-06-15 |
| 2025-10-31 | $11.91M 10-Q · filed 2026-09-14 |
| 2025-07-31 | $11.93M 10-Q · filed 2026-09-14 |
| 2025-04-30 | $12.12M 10-Q · filed 2026-09-14 |
| 2025-01-31 | $12.00M 10-Q · filed 2026-06-15 |
| 2024-10-31 | $13.72M 10-Q · filed 2026-09-14 |
| 2024-07-31 | $13.69M 10-Q · filed 2025-09-15 |
| 2024-04-30 | $13.95M 10-Q · filed 2025-09-15 |
| 2024-01-31 | $14.16M 10-Q · filed 2025-06-16 |
| 2023-10-31 | $16.13M 10-K · filed 2026-01-29 |
| 2023-07-31 | $16.19M 10-Q · filed 2024-09-16 |
| 2023-04-30 | $15.67M 10-Q · filed 2024-09-16 |
| 2023-01-31 | $16.99M 10-Q · filed 2024-06-14 |
| 2022-10-31 | $16.56M 10-K · filed 2025-01-29 |
| 2022-07-31 | $16.15M 10-Q · filed 2023-09-14 |
| 2022-04-30 | $15.89M 10-Q · filed 2023-09-14 |
| 2022-01-31 | $17.43M 10-Q · filed 2023-06-14 |
| 2022-01-30 | $17.43M 10-Q · filed 2022-06-14 |
| 2021-10-31 | $18.91M 10-K · filed 2024-01-29 |
| 2021-07-31 | $23.84M 10-Q · filed 2022-09-14 |
| 2021-04-30 | $21.55M 10-Q · filed 2022-09-14 |
| 2021-01-31 | $21.29M 10-Q · filed 2022-03-17 |
| 2021-01-30 | $21.29M 10-Q · filed 2022-06-14 |
| 2020-10-31 | $22.72M 10-K · filed 2023-01-30 |
| 2020-07-31 | $22.58M 10-Q · filed 2021-09-14 |
| 2020-04-30 | $21.80M 10-Q · filed 2021-09-14 |
| 2020-01-31 | $21.13M 10-Q · filed 2021-09-14 |
| 2019-10-31 | $20.61M 10-K · filed 2022-02-11 |
| 2019-07-31 | $21.79M 10-Q · filed 2020-09-14 |
| 2019-04-30 | $21.36M 10-Q · filed 2020-09-14 |
| 2019-01-31 | $20.69M 10-Q · filed 2020-09-14 |
| 2018-10-31 | $20.26M 10-K · filed 2021-02-01 |
| 2018-07-31 | $18.72M 10-Q · filed 2019-09-16 |
| 2018-04-30 | $18.02M 10-Q · filed 2019-09-16 |
| 2018-01-31 | $18.17M 10-Q · filed 2019-09-16 |
| 2017-10-31 | $20.75M 10-K · filed 2020-01-29 |
| 2017-07-31 | $21.04M 10-Q · filed 2017-09-14 |
| 2017-04-30 | $21.14M 10-Q · filed 2017-06-14 |
| 2017-01-31 | $21.45M 10-Q · filed 2017-03-17 |
| 2016-10-31 | $21.81M 10-K · filed 2019-01-29 |
| 2016-07-31 | $22.31M 10-Q · filed 2016-09-14 |
| 2016-04-30 | $22.42M 10-Q · filed 2016-06-14 |
| 2016-01-31 | $22.30M 10-Q · filed 2016-03-16 |
| 2015-10-31 | $21.96M 10-K · filed 2018-01-29 |
| 2015-07-31 | $21.50M 10-Q · filed 2015-09-14 |
| 2015-04-30 | $21.05M 10-Q · filed 2015-06-15 |
| 2015-01-31 | $20.68M 10-Q · filed 2015-03-17 |
| 2014-10-31 | $20.51M 10-K · filed 2017-01-31 |
| 2014-07-31 | $19.66M 10-Q · filed 2014-09-15 |
| 2014-04-30 | $19.08M 10-Q · filed 2014-06-16 |
| 2014-01-31 | $18.74M 10-Q · filed 2014-03-17 |
| 2013-10-31 | $18.05M 10-K · filed 2016-01-29 |
| 2013-07-31 | $16.78M 10-Q · filed 2013-09-16 |
| 2013-04-30 | $15.49M 10-Q · filed 2013-06-14 |
| 2013-01-31 | $14.13M 10-Q · filed 2013-03-18 |
| 2012-10-31 | $12.88M 10-K · filed 2015-01-29 |
| 2012-07-31 | $11.76M 10-Q · filed 2012-09-14 |
| 2012-04-30 | $10.53M 10-Q · filed 2012-06-14 |
| 2012-01-31 | $9.32M 10-Q · filed 2012-03-16 |
| 2011-10-31 | $8.24M 10-K · filed 2014-01-29 |
| 2011-07-31 | $7.42M 10-Q · filed 2011-09-14 |
| 2010-10-31 | $5.07M 10-K · filed 2013-01-29 |
| 2009-10-31 | $4.66M 10-K/A · filed 2012-01-31 |